Keyword Search Results for "stable vascular disease"

Cotter, G., Cannon, C. P., McCabe, C. H., Michowitz, Y., Kaluski, E., Charlesworth, A., Milo, O., Bentley, J., Blatt, A., Krakover, R., Zimlichman, R., Reisin, L., Marmor, A., Lewis, B., Vered, Z., Caspi, A., Braunwald, E. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2003;145(4):622-7. Abstract

Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., Gerszten, R. E. Metabolomic identification of novel biomarkers of myocardial ischemia Circulation. 2005;112(25):3868-75. Abstract

Januzzi, J. L., Jr., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O'Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R., Lewandrowski, K. B., Lloyd-Jones, D. M., Wu, A. H. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol. 2007;50(7):607-13. Abstract

Omland, T., Sabatine, M. S., Jablonski, K. A., Rice, M. M., Hsia, J., Wergeland, R., Landaas, S., Rouleau, J. L., Domanski, M. J., Hall, C., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial J Am Coll Cardiol. 2007;50(3):205-14. Abstract

Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease Circulation. 2007;115(12):1528-36. Abstract

Sabatine, M. S., Morrow, D. A., O'Donoghue, M., Jablonksi, K. A., Rice, M. M., Solomon, S., Rosenberg, Y., Domanski, M. J., Hsia, J. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease Arterioscler Thromb Vasc Biol. 2007;27(11):2463-9. Abstract

Steinberg, B. A., Steg, P. G., Bhatt, D. L., Fonarow, G. C., Zeymer, U., Cannon, C. P. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) Am J Cardiol. 2007;99(9):1212-5. Abstract

Cannon, C. P. Cardiovascular disease and modifiable cardiometabolic risk factors Clin Cornerstone. 2008;9(2):24-38; discussion 39-41. Abstract

Hsia, J., Jablonski, K. A., Rice, M. M., Sabatine, M. S., Zabalgoitia, M., Maggioni, A., Cuddy, T. E., Domanski, M. J., Geller, N. L., Flaker, G., Solomon, S., Omland, T., Rouleau, J. L., Peace Investigators Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function Am J Cardiol. 2008;101(4):457-61. Abstract

Iakoubova, O. A., Tong, C. H., Rowland, C. M., Kirchgessner, T. G., Young, B. A., Arellano, A. R., Shiffman, D., Sabatine, M. S., Campos, H., Packard, C. J., Pfeffer, M. A., White, T. J., Braunwald, E., Shepherd, J., Devlin, J. J., Sacks, F. M. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials J Am Coll Cardiol. 2008;51(4):435-43. Abstract

Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., Chan, P. S. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial Circulation Cardiovascular quality and outcomes. 2009;2(4):344-53. Abstract

Cannon, C. P., Dansky, H. M., Davidson, M., Gotto, A. M., Jr., Brinton, E. A., Gould, A. L., Stepanavage, M., Liu, S. X., Shah, S., Rubino, J., Gibbons, P., Hermanowski-Vosatka, A., Binkowitz, B., Mitchel, Y., Barter, P. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib Am Heart J. 2009;158(4):513-519 e3. Abstract

Morrow DA, Scirica BM, Fox KA, Berman G, Strony J, Veltri E, Bonaca MP, Fish P, McCabe CH, Braunwald E. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2˚P)-TIMI 50 trial. Am Heart J. 2009;158:335-341 e3. Abstract

Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., Braunwald, E., Prevention of Events with Angiotensin Converting Enzyme Inhibition Trial, Investigators A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med. 2009;361(26):2538-47. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Jarolim, P., Braunwald, E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 European heart journal. 2009;30(2):162-9. Abstract

Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., Scirica, B. M., Murphy, S. A., Cannon, C. P., Cogent Investigators Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med. 2010;363(20):1909-17. Abstract

Cannon, C. P., Rhee, K. E., Califf, R. M., Boden, W. E., Hirsch, A. T., Alberts, M. J., Cable, G., Shao, M., Ohman, E. M., Steg, P. G., Eagle, K. A., Bhatt, D. L. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) Am J Cardiol. 2010;105(4):445-52. Abstract

Cannon, C. P., Shah, S., Dansky, H. M., Davidson, M., Brinton, E. A., Gotto, A. M., Stepanavage, M., Liu, S. X., Gibbons, P., Ashraf, T. B., Zafarino, J., Mitchel, Y., Barter, P. Safety of anacetrapib in patients with or at high risk for coronary heart disease N Engl J Med. 2010;363(25):2406-15. Abstract

Tam, L. M., Fonarow, G. C., Bhatt, D. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Giugliano, R. P. Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program Circulation. 2010;122(21):NA.

Mega, J. L., Hochholzer, W., Frelinger, A. L., Kluk, M. J., Isserman, S., Rogers, W. J., Angiolillo, D. J., Kereiakes, D. J., Ruff, C. T., Berg, D. D., Cyr, J., Scirica, B. M., Grip, L., Mesa, R. A., Mattimore, J. F., Longtine, J. A., Michelson, A. D., Sabatine, M. S. ELEVATE-TIMI 56: Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56 Circulation. 2011;124(21):2371-2372. Abstract

O'Donoghue, M. L., Mallat, Z., Morrow, D. A., Benessiano, J., Sloan, S., Omland, T., Solomon, S. D., Braunwald, E., Tedgui, A., Sabatine, M. S. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease Clinical chemistry. 2011;57(9):1311-7. Abstract

Wiviott, S. D., Flather, M. D., O'Donoghue, M. L., Goto, S., Fitzgerald, D. J., Cura, F., Aylward, P., Guetta, V., Dudek, D., Contant, C. F., Angiolillo, D. J., Bhatt, D. L., Lancelot-Cad Investigators Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin-Coronary Artery Disease Trial Circulation. 2011;123(17):1854-63. Abstract

Bohula May, Erin A, Bonaca, Marc P, Scirica, Benjamin M, Morais, Joao, Nieminen, Markku, Murphy, Sabina A, Braunwald, Eugene, Morrow, David A Abstract 19221: Rates of Arterial Revascularization in Patients Treated with Vorapaxar vs. Placebo in the TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A19221.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, Wiviott, Stephen D, Goto, Shinya, Nilsen, Dennis, Bonarjee, Vernon, Murphy, Sabina A, Morrow, David A Abstract 19144: New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A19144.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy, SA. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366:1404-13. Abstract

O'Donoghue, M. L., Bhatt, D. L., Flather, M. D., Goto, S., Angiolillo, D. J., Goodman, S. G., Zeymer, U., Aylward, P. E., Montalescot, G., Ziecina, R., Kobayashi, H., Ren, F., Wiviott, S. D. Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program J Thromb Thrombolysis. 2012;34(1):36-43. Abstract

O'Malley, Ryan G, Morrow, David A, Bonaca, Marc P, Jarolim, Petr, Scirica, Benjamin M, Murphy, Sabina A, Conrad, Michael J, Cannon, Christopher P, Braunwald, Eugene, Sabatine, Marc S Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22 Circulation. 2012;126(21 Supplement):A11559.

Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2˚P-TIMI 50 trial Lancet. 2012;380:1317-24. Abstract

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Betriu, Amadeo, Moliterno, David J, Corbalan, Ramon, Murphy, Sabina A, Morrow, David A Abstract 14508: Vorapaxar for Secondary Prevention after Myocardial Infarction According to Aspirin Dose - Insights from the TRA2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14508.

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Diehm, Curt H, Hankey, Graeme J, Moliterno, David J, Murphy, Sabina A, Morrow, David A Abstract 14419: Natural History of Atherothrombotic Events According to the Primary Diseased Vascular Bed - Insights from the TRA2P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14419.

Udell, J. A., Scirica, B. M., Braunwald, E., Raz, I., Steg, P. G., Davidson, J., Hirshberg, B., Bhatt, D. L. Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus Clin Cardiol. 2012;35(12):722-9. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Smith, S. C., Jr., Ohman, E. M., Eagle, K. A., Goto, S., Cho, J. I., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis Arch Intern Med. 2012;172(14):1086-95. Abstract

Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P. G., Bhatt, D. L., Reid, C. M. Outcomes and Excess Costs among Patients with Cardiovascular Disease Heart Lung Circ. 2013;22(9):724-30. Abstract

Bohula May, E. A., Scirica, B., Bonaca, M., Murphy, S., Braunwald, E. B., Morrow, D., Brigham and Women's Hospital Prognostic Value of High-Sensitivity CRP for Cardiovascular Outcomes in TRA 2P - TIMI 50 Journal of the American College of Cardiology. 2013;61(10):A287.

Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, Lamp JM, Murphy SA, Braunwald E, Morrow DA Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA 2˚P-TIMI 50 Circulation. 2013;127:1522-9. Abstract

Bonaca, M. P., Beckman, J. Management of asymptomatic carotid artery stenosis Curr Treat Options Cardiovasc Med. 2013;15(2):252-63. Abstract

Bonaca, M., Creager, M. A., Olin, J., Scirica, B., Bohula May, E. A., Murphy, S., Braunwald, E. B., Morrow, D., Timi Study Group Vorapaxar Reduces Peripheral revascularization Regardless of the Number of Diseased Territories: Insights from the TRA 2P - TIMI 50 Trial Journal of the American College of Cardiology. 2013;61(10):A504.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, Wiviott, Stephen D, Murphy, Sabina A, Morrow, David A Abstract 18928: Vorapaxar Reduces Coronary Stent Thrombosis: Results From the TRA2P-TIMI 50 Trial Circulation. 2013;128(22 Supplement):A18928.

Cavender, Matthew A, Scirica, Benjamin, Bonaca, Marc P, Morais, Joao, Oude Ophius, Ton, Dalby, Tony, Murphy, Sabina, Braunwald, Eugene, Morrow, David Abstract 10398: Vorapaxar in Patients With Diabetes and Prior MI: Findings From the TRA 2P - TIMI 50 Trial Circulation. 2013;128(22 Supplement):A10398.

Ducrocq, G., Amarenco, P., Labreuche, J., Alberts, M. J., Mas, J. L., Ohman, E. M., Goto, S., Lavallee, P., Bhatt, D. L., Steg, P. G. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease Circulation. 2013;127(6):730-8. Abstract

Ferreiro, J. L., Bhatt, D. L., Ueno, M., Bauer, D., Angiolillo, D. J. Impact of Smoking on Long-Term Outcomes in Patients with Atherosclerotic Vascular Disease Treated with Aspirin or Clopidogrel: Insights from the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Goyal, Abhinav, Steg, Ph. Gabriel, Smith, Jr., Sidney C, Eagle, Kim A, Ohman, E. Magnus, Koplan, Jeffrey P, Hoffman, Elaine B, Im, KyungAh, Goto, Shinya, Wilson, Peter W, Bhatt, Deepak L Abstract 13411: Cigarette Smoking is Associated With a Greater Hazard for Adverse Outcomes in Women Compared With Men: Insights From the Global REACH Registry Circulation. 2013;128(22 Supplement):A13411.

Holmes, M. V., Simon, T., Exeter, H. J., Folkersen, L., Asselbergs, F. W., Guardiola, M., Cooper, J. A., Palmen, J., Hubacek, J. A., Carruthers, K. F., Horne, B. D., Brunisholz, K. D., Mega, J. L., van Iperen, E. P., Li, M., Leusink, M., Trompet, S., Verschuren, J. J., Hovingh, G. K., Dehghan, A., Nelson, C. P., Kotti, S., Danchin, N., Scholz, M., Haase, C. L., Rothenbacher, D., Swerdlow, D. I., Kuchenbaecker, K. B., Staines-Urias, E., Goel, A., Hooft, F. V., Gertow, K., de Faire, U., Panayiotou, A. G., Tremoli, E., Baldassarre, D., Veglia, F., Holdt, L. M., Beutner, F., Gansevoort, R. T., Navis, G. J., Leach, I. M., Breitling, L. P., Brenner, H., Dallmeier, D., Franco-Cereceda, A., Boer, J., Stephens, J. W., Hofker, M. H., Tedgui, A., Hofman, A., Uitterlinden, A. G., Adamkova, V., Pitha, J., Onland-Moret, N. C., Cramer, M. J., Nathoe, H. M., Spiering, W., Klungel, O. H., Kumari, M., Whincup, P. H., Morrow, D. A., Braund, P. S., Hall, A. S., Olsson, A. G., Doevendans, P. A., Trip, M. D., Tobin, M. D., Hamsten, A., Watkins, H., Koenig, W., Nicolaides, A. N., Teupser, D., Day, I. N., Carlquist, J. F., Gaunt, T. R., Ford, I., Sattar, N., Tsimikas, S., Schwartz, G. G., Lawlor, D. A., Morris, R. W., Sandhu, M. S., Poledne, R., Maitland-van der Zee, A. H., Khaw, K. T., Keating, B. J., van der Harst, P., Price, J. F., Mehta, S. R., Yusuf, S., Witteman, J. C., Franco, O. H., Jukema, J. W., de Knijff, P., Tybjaerg-Hansen, A., Rader, D. J., Farrall, M., Samani, J., Kivimaki, M., Fox, K. A., Humphries, S. E., Anderson, J. L., Boekholdt, S. M., Palmer, T. M., Eriksson, P., Pare, G., Hingorani, A. D., Sabatine, M. S., Mallat, Z., Casas, J. P., Talmud, P. J. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Huo, Y., Wischgoll, T., Choy, J. S., Sola, S., Navia, J. L., Teague, S. D., Bhatt, D. L., Kassab, G. S. CT-based Diagnosis of Diffuse Coronary Artery Disease on the Basis of Scaling Power Laws Radiology. 2013;NA(NA):NA. Abstract

Kohli, P., Steg, P. G., Cannon, C. P., Smith, S. C., Jr., Eagle, K. A., Ohman, E. M., Alberts, M. J., Hoffman, E., Guo, J., Simon, T., Sorbets, E., Goto, S., Bhatt, D. L., Reach Registry Investigators NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Am J Med. 2013;NA(NA):NA. Abstract

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Hoffman, E., Goto, S., Ohman, E. M., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Am J Med. 2013;126(8):693-700 e1. Abstract

Maddox, T. M., Chan, P. S., Spertus, J. A., Tang, F., Jones, P., Ho, P. M., Bradley, S. M., Tsai, T. T., Bhatt, D. L., Peterson, P. N. Variation in CAD Secondary Prevention Prescription among Outpatient Cardiology Practices: Insights from the NCDR(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Magnani, Giulia, Morrow, David A, Scirica, Benjamin M, Sabatine, Marc S, Murphy, Sabina A, Bonaca, Marc P Abstract 18728: Patterns of Antiplatelet Use in Patients With Stable Atherosclerosis: Insights From the Tra 2{degrees}P-timi 50 Trial Circulation. 2013;128(22 Supplement):A18728.

Morrow DA, Alberts MJ, Mohr JP, Ameriso SF, Bonaca MP, Goto S, Hankey GJ, Murphy SA, Scirica BM, Braunwald E. Efficacy and safety of vorapaxar in patients with prior ischemic stroke. Stroke. 2013;44:691-8. Abstract

Murphy, S., Bohula May, Erin A., Bonaca, M. P., Scirica, B., Braunwald, E. B., Morrow, D., Brigham and Women's Hospital Procedural Bleeding with Vorapaxar versus Placebo in TRA 2P - TIMI 50 Trial Journal of the American College of Cardiology. 2013;61(10):A30.

O'Donoghue, M., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. P., Solomon, S. D., Domanski, M., Arai, K., Chiuve, S. E., Cannon, C. P., Sacks, F. M., Sabatine, M. S. Lipoprotein (a) For Risk Assessment in Patients with Established Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

O'Malley, R. G., Sabatine, M. S., Bonaca, M. P., Murphy, S., Jarolim, P., Conrad, M. J., Cannon, C. P., Braunwald, E. B., Morrow, D. A. Prognostic Performance of Srial High Sensitivity Cardiac Troponin Determination in Stable Ischemic Heart Disease: Analysis from PROVE IT-TIMI 22 Journal of the American College of Cardiology. 2013;61(10):A283.

Omland, T., Pfeffer, M. A., Solomon, S. D., de Lemos, J. A., Rosjo, H., Saltyte Benth, J., Maggioni, A., Domanski, M. J., Rouleau, J. L., Sabatine, M. S., Braunwald, E., Peace Investigators Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Rodriguez, F., Bhatt, D. L., Steg, P., Kumbhani, D. J., Umez-Eronini, A., Hoffman, E. P., Cannon, C. P. Predictors of Long-Term Adherence to Evidence-Based Cardiovascular Disease Medications in OUtpatients with Atherothrombotic Disease Journal of the American College of Cardiology. 2013;61(10):A377.

Rodriguez, F., Cannon, C. P., Steg, P. G., Kumbhani, D. J., Goto, S., Smith, S. C., Eagle, K. A., Ohman, E. M., Umez-Eronini, A. A., Hoffman, E., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry Clin Cardiol. 2013;NA(NA):NA. Abstract

Seif, F., Patel, S. R., Walia, H. K., Rueschman, M., Bhatt, D. L., Blumenthal, R. S., Quan, S. F., Gottlieb, D. J., Lewis, E. F., Patil, S. P., Punjabi, N. M., Babineau, D. C., Redline, S., Mehra, R. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk J Hypertens. 2013;NA(NA):NA. Abstract

Sirimarco, G., Amarenco, P., Labreuche, J., Touboul, P. J., Alberts, M., Goto, S., Rother, J., Mas, J. L., Bhatt, D. L., Steg, P. G., Reach Registry Investigators Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis Stroke. 2013;44:373-9. Abstract

Steg, P. G., Bhatt, D. L., Hamm, C. W., Stone, G. W., Gibson, C. M., Mahaffey, K. W., Leonardi, S., Liu, T., Skerjanec, S., Day, J. R., Iwaoka, R. S., Stuckey, T. D., Gogia, H. S., Gruberg, L., French, W. J., White, H. D., Harrington, R. A. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet. 2013;NA(NA):NA. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Eagle, K. A., Ohman, E. M., Goto, S., Alsheikh-Ali, A. A., Porath, A., Corbalan, R., Umez-Eronini, A. A., Hoffman, E. B., Wilson, P. W., Bhatt, D. L., on Behalf of the Reduction of Atherothrombosis for Continued Health Registry, Investigators Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis Eur J Prev Cardiol. 2013;NA(NA):NA. Abstract

Ademi, Z., Liew, D., Gorelik, A., Bohensky, M., Zomer, E., Hollingsworth, B., Steg, G., Bhatt, D. L., Reid, C. M. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data Int J Cardiol. 2014;NA(NA):NA. Abstract

Cavender, Matthew, Steg, Philippe, Smith, Sidney, Eagle, Kim, Ohman, Erik, Goto, Shinya, Kuder, Julia, Im, Kyungah, Bhatt, Deepak Cardiovascular Event Rates in Patients with Diabetes: Insights from the International Reach Registry Journal of the American College of Cardiology. 2014;63(12, Supplement):A1340.

Kato, Eri Toda, Bonaca, Marc, Morrow, David, Jarolim, Petr, Sloan, Sarah, Solomon, Scott, Braunwald, Eugene, Sabatine, Marc GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) AND THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Journal of the American College of Cardiology. 2014;63(12, Supplement):A1525.

Kidd, Stephen, Bonaca, Marc, Scirica, Benjamin, Murphy, Sabina, Braunwald, Eugene, Morrow, David UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50 Journal of the American College of Cardiology. 2014;63(12, Supplement):A1568.

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Goto, S., Ohman, E. M., Elbez, Y., Sritara, P., Baumgartner, I., Banerjee, S., Creager, M. A., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry Eur Heart J. 2014;NA(NA):NA. Abstract

Udell, J. A., Morrow, D. A., Jarolim, P., Sloan, S., Hoffman, E. B., O'Donnell, T. F., Vora, A. N., Omland, T., Solomon, S. D., Pfeffer, M. A., Braunwald, E., Sabatine, M. S. Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease J Am Coll Cardiol. 2014;NA(NA):NA. Abstract